Department of Medicine and Surgery, Unit of Pathology, University of Insubria, via O. Rossi 9, 21100, Varese, Italy.
Department of Urology, ASST Lariana, Como, Italy.
Virchows Arch. 2021 Jul;479(1):69-78. doi: 10.1007/s00428-021-03023-7. Epub 2021 Jan 17.
Neuroendocrine carcinomas (NECs) of the urinary bladder are very rare and can be observed in the context of mixed neuroendocrine/non-neuroendocrine neoplasms (MiNENs), most frequently in association with urothelial carcinoma. Small cell NECs are far more common than large cell NECs (LCNECs), which are exceedingly rare. We describe a primary MiNEN of the urinary bladder, composed of a LCNEC and of an adenocarcinoma, in which the neuroendocrine component reached complete pathological regression after neoadjuvant M-VAC chemotherapy, whereas the non-neuroendocrine component of the tumor progressed to metastatic disease. Compared to mixed neuroendocrine/non-neuroendocrine neoplasms described in the literature until now, this appears to be a unique case that expands the spectrum of neuroendocrine neoplasia of the urinary bladder.
膀胱神经内分泌癌(NEC)非常罕见,可在混合性神经内分泌/非神经内分泌肿瘤(MiNEN)的背景下观察到,最常与尿路上皮癌相关。小细胞 NEC 比大细胞 NEC(LCNEC)更为常见,后者极为罕见。我们描述了一例原发性膀胱 MiNEN,由 LCNEC 和腺癌组成,其中神经内分泌成分在新辅助 M-VAC 化疗后达到完全病理缓解,而肿瘤的非神经内分泌成分进展为转移性疾病。与迄今为止文献中描述的混合性神经内分泌/非神经内分泌肿瘤相比,这似乎是一个独特的病例,扩展了膀胱神经内分泌肿瘤的范围。